Immersion in both Universities
Although registered in either Oxford or Cambridge as their home base, all students will have ample opportunity to spend periods of time as a visitor in the second University, taking part in ongoing collaborations.
Training & Education
INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance
INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance
The INEOS Oxbridge Doctoral Initiative is a programme from the Ineos Oxford Institute for Antimicrobial Research (IOI), University of Oxford and University of Cambridge to train the next generation of outstanding scientific champions to tackle the global challenge of antimicrobial resistance (AMR).
This is our call to the brightest minds to join us in tackling the growing global threat of antimicrobial resistance using cutting-edge science and innovation. This presents you with an extraordinary opportunity to make an important scientific contribution while training with internationally leading scientists at Oxford and Cambridge.
About AMR
Antimicrobial resistance (AMR) – when microbes, such as bacteria and viruses, outwit our medicines and cause untreatable infections – is already a huge and growing health problem around the world. Recent data published in The Lancet suggests that there may have already been nearly 5 million global deaths related to drug resistant infections in 2019. The World Health Organisation (WHO) estimates that by 2050, this figure will increase to 10 million, overtaking the number of cancer related deaths and making antimicrobial resistance one of the most pressing health problems faced by humanity today.
About the programme
The INEOS Oxbridge Doctoral Initiative on AMR integrates the expertise and capabilities of two Universities that are globally recognised for excellence in health science research. This is funded by the INEOS Oxford Institute, with studentships fully funded for 3.5 years (fixed term).
3 studentships will be awarded in Oxford (DPhil) and 4 will be awarded in Cambridge (PhD), but students will be encouraged to train in both Universities. This provides the chance to experience the best of both academic environments and their established networks.
The programme offers:
Collaboration
Each project is distinct and unique for that student, but there will be the opportunity to collaborate with other students and projects within the initiative, with the additional possibility of input from industry.
Funding
Our studentships are fully funded for three and a half years, through the generous support of the INEOS Oxford Institute. This funding covers UK/international University of Cambridge & Oxford fees in addition to living costs (stipend), which will be equivalent to the standard Wellcome stipend rate.
Future prospects
By the time you graduate, you will have acquired skills that are in high demand worldwide. This includes expertise in drug discovery, machine learning and analysis of big data. Such skills will support your future ambitions wherever these take you, including academia, pharma and private-sector companies.
Applications
The application window for the current academic year has closed.
This page will be updated when applications reopen for the 2024-2025 academic year.
Learn more
What is AMR?
Learn more about antimicrobial resistance (AMR)
Training & Education
We are training early- and mid-career researchers to advance the interdisciplinary science needed to address AMR
Research
Learn more about our main areas of focus, researchers, labs, capabilities and publications